Given the pathological and clinical overlap between FBD and Alzheimer’s disease, it is intriguing to consider the amyloid cascade hypothesis [58] initiating via different amyloids from distinct cellular sources—converging on a disease pathogenesis featuring tau pathology, inflammation, neurodegeneration, and dementia-like symptoms. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.